We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

25 hedge funds and large institutions have $447K invested in LakeShore Biopharma Warrants in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital invested

Capital invested by funds: $266K → $447K (+$181K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.57% less ownership

Funds ownership: 5.9% → 5.33% (-0.57%)

11% less funds holding

Funds holding: 28 → 25 (-3)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.36%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
3
Increased
1
Reduced
1
Closed
5
Calls
$62K
Puts
–
Net Calls
+$62K
Net Calls Change
+$29K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$1.96K
2
Citadel Advisors
Citadel Advisors
Florida
+$1.22K
3
UBS Group
UBS Group
Switzerland
+$4

Top Sellers

Rank Fund Capital Flow
1
SVI
Strategic Vision Investment
Hong Kong
-$1.48K
2
EC
Elequin Capital
New York
-$1.43K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$341
4
WAM
Wolverine Asset Management
Illinois
-$45
5
CS
Clear Street
New York
-$13
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Athos Capital
Hong Kong
$93K – – –
LP
2
LMR Partners
United Kingdom
$75.4K – – –
VAM
3
Valliance Asset Management
Hong Kong
$53.7K – – –
Jane Street
4
Jane Street
New York
$35.7K – – –
HCM
5
Highbridge Capital Management
New York
$35.1K – – –
BP
6
BFAM Partners
Hong Kong
$28.1K – – –
FC
7
Finepoint Capital
Massachusetts
$25K – – –
CAC
8
Cowen and Company
New York
$16.9K +$1.96K +35,213 +18%
BCL
9
Bracebridge Capital LLC
Massachusetts
$16.6K – – –
QGA
10
Q Global Advisors
Texas
$9K – – –
WA
11
Whitebox Advisors
Minnesota
$8.95K – – –
Calamos Advisors
12
Calamos Advisors
Illinois
$7.45K – – –
Walleye Capital
13
Walleye Capital
New York
$7.15K – – –
SCM
14
Saba Capital Management
New York
$6.97K – – –
CF
15
Cantor Fitzgerald
New York
$6K – – –
SCM
16
Shaolin Capital Management
Florida
$5.46K – – –
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$5.1K – – –
EAM
18
Exos Asset Management
New York
$3.58K +$2.79K +50,000 New
CS
19
Clear Street
New York
$3.39K -$13 -239 -0.5%
MC
20
Meteora Capital
Florida
$1.79K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$1.12K +$1.22K +21,918 New
SIA
22
SkyView Investment Advisors
New Jersey
$1K – – –
AA
23
Ancora Advisors
Ohio
$362 – – –
HIM
24
HGC Investment Management
Ontario, Canada
$358 – – –
TRCT
25
Tower Research Capital (TRC)
New York
$9 – – –
1
2

LSBPW Hedge Fund Activity: Q1 2024 in Review

25 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q1 2024, worth a combined $447K — up 68% from $266K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of LSBPW and 3 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Cowen and Company, adding an estimated $1.96K. The largest seller was Strategic Vision Investment, exiting entirely with an estimated $1.48K sold.

  • 25 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q1 2024, down from 28 in Q4 2023.
  • Funds reported $447K of LakeShore Biopharma Warrants stock for Q1 2024, up 68% quarter-over-quarter.
  • 3 funds opened new LakeShore Biopharma Warrants positions in Q1 2024 and 5 closed out, a net change of -2 holders.
  • The largest LakeShore Biopharma Warrants buyer in Q1 2024 was Cowen and Company, an estimated $1.96K added.
  • The largest LakeShore Biopharma Warrants seller in Q1 2024 was Strategic Vision Investment, an estimated $1.48K sold.

Based on aggregated 13F filings for Q1 2024.